CNS Drugs. 2006;20(3):233-55.

Sertindole : a review of its use in schizophrenia.

Source

Adis International Limited, Auckland, New Zealand.

Abstract

Oral sertindole (Serdolect) is an atypical antipsychotic approved in the EU for once-daily use in patients with schizophrenia who are intolerant to at least one other antipsychotic agent. Extensive data from post-marketing studies do not indicate an excess of overall mortality with sertindole. Sertindole is at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. Sertindole improves negative symptoms, and is also effective for the treatment of neuroleptic-resistant schizophrenia. Sertindole is generally well tolerated and is associated with a low rate of extrapyramidal symptoms (EPS). Thus, sertindole is a useful option in the treatment of patients with schizophrenia.

PMID:: 16529528; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Schizophrenia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review A review of the efficacy, tolerability and safety of sertindole in clinical trials. [CNS Drugs. 2004]
Review A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L, Steinert T. CNS Drugs. 2004; 18 Suppl 2:19-30; discussion 41-3.
Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group. [Psychopharmacol Bull. 1998]
Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG, Wozniak P, Mack RJ, McCarthy BG. Psychopharmacol Bull. 1998; 34(1):61-9.
Review Emerging treatments in the management of schizophrenia - focus on sertindole. [Drug Des Devel Ther. 2010]
Review Emerging treatments in the management of schizophrenia - focus on sertindole.
Muscatello MR, Bruno A, Pandolfo G, Micò U, Settineri S, Zoccali R. Drug Des Devel Ther. 2010 Sep 7; 4:187-201. Epub 2010 Sep 7.
A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia. [Int Clin Psychopharmacol. 2006]
A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
Azorin JM, Strub N, Loft H. Int Clin Psychopharmacol. 2006 Jan; 21(1):49-56.
Review Sertindole: efficacy and safety in schizophrenia. [Expert Opin Pharmacother. 2006]
Review Sertindole: efficacy and safety in schizophrenia.
Lindström E, Levander S. Expert Opin Pharmacother. 2006 Sep; 7(13):1825-34.

See reviews... See all...

Cited by 2 PubMed Central articles

Critical appraisal of lurasidone in the management of schizophrenia. [Neuropsychiatr Dis Treat. 2012]
Critical appraisal of lurasidone in the management of schizophrenia.
Caccia S, Pasina L, Nobili A. Neuropsychiatr Dis Treat. 2012; 8:155-68. Epub 2012 Apr 17.
Emerging role of sertindole in the management of schizophrenia. [Neuropsychiatr Dis Treat. 2010]
Emerging role of sertindole in the management of schizophrenia.
Cincotta SL, Rodefer JS. Neuropsychiatr Dis Treat. 2010 Sep 7; 6:429-41. Epub 2010 Sep 7.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Sertindole : a review of its use in schizophrenia.
Sertindole : a review of its use in schizophrenia.
CNS Drugs. 2006 ;20(3):233-55.

PubMed
An endoglucanase is involved in infection of rice roots by the not-cellulose-met...
An endoglucanase is involved in infection of rice roots by the not-cellulose-metabolizing endophyte Azoarcus sp. strain BH72.
Mol Plant Microbe Interact. 2006 Feb ;19(2):181-8.

PubMed
A Pseudomonas syringae pv. tomato avrE1/hopM1 mutant is severely reduced in grow...
A Pseudomonas syringae pv. tomato avrE1/hopM1 mutant is severely reduced in growth and lesion formation in tomato.
Mol Plant Microbe Interact. 2006 Feb ;19(2):99-111.

PubMed
Loss of glucocorticoid fast feedback in depression.
Loss of glucocorticoid fast feedback in depression.
Arch Gen Psychiatry. 1991 Aug ;48(8):693-9.

PubMed
Use of a prospective space-time scan statistic to prioritize shigellosis case in...
Use of a prospective space-time scan statistic to prioritize shigellosis case investigations in an urban jurisdiction.
Public Health Rep. 2006 Mar-Apr ;121(2):133-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: